Edgestream Partners’s AtriCure ATRC Stock Holding History

Edgestream Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,178	Closed	-$863K	–	805
2023 Q4	$863K	Buy	+24,178	New	+$899K	0.06%	481

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgestream Partners's ATRC Position: Q1 2024 in Review

Edgestream Partners sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 24,178 shares — an estimated $863K sold.

Edgestream Partners first reported a position in ATRC in Q4 2023 and held it in 1 quarter. The position peaked at $863K in Q4 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

Edgestream Partners reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
Edgestream Partners sold 24,178 AtriCure shares in Q1 2024, an estimated $863K.
Edgestream Partners first reported a position in AtriCure in Q4 2023 and held it in 1 quarter.
Edgestream Partners's AtriCure position peaked at $863K in Q4 2023.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Edgestream Partners's 13F filing for Q1 2024, filed 10 May 2024.